RxDoctor Payments Data

Whitney Colella, PA

Medical · Alcoa, TNNPI 1831589092

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations.

$4,998in general payments, 2019–2025

Across 219 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$652
  • Novartis$630
  • Sun Pharmaceutical Industries Inc.$533
  • E.r. Squibb & Sons, L.L.C.$533
  • Johnson & Johnson$452
  • UCB, Inc.$451
  • plus $2K from 11 others

What the payments were for

  • Food & beverage$4,84997%
  • Education$1493%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,998 in reported general payments places this provider in the 85th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$82,352
Medicare patients
331
Services billed
1,506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil79$6,134
Clobetasol Propionate84$3,089
Triamcinolone Acetonide63$1,072
Ketoconazole53$919
Doxycycline Hyclate37$695
Ammonium Lactate19$690
Metronidazole15$583
Mupirocin56$438

Paid to pharmacies, not to this prescriber.

Other medical in Alcoa

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →